Dynasore _Dynamin 抑制劑 - MedChemExpress_第1頁(yè)
Dynasore _Dynamin 抑制劑 - MedChemExpress_第2頁(yè)
Dynasore _Dynamin 抑制劑 - MedChemExpress_第3頁(yè)
Dynasore _Dynamin 抑制劑 - MedChemExpress_第4頁(yè)
全文預(yù)覽已結(jié)束

下載本文檔

版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemEDynasoreCat. No.: HY-15304CAS No.: 304448-55-3分式: CHNO分量: 322.31作靶點(diǎn): Dynamin; Autophagy作通路: Cytoskeleton; Autophagy儲(chǔ)存式: Powder -20C 3 years4C 2 yearsIn solvent -80C 6 months-20C 1 month溶解性數(shù)據(jù)體外實(shí)驗(yàn) DMSO : 50 mg/mL (155.13 mM)* mean

2、s soluble, but saturation unknown.Mass Solvent1 mg 5 mg 10 mg Concentration制備儲(chǔ)備液1 mM 3.1026 mL 15.5130 mL 31.0260 mL5 mM 0.6205 mL 3.1026 mL 6.2052 mL10 mM 0.3103 mL 1.5513 mL 3.1026 mL請(qǐng)根據(jù)產(chǎn)品在不同溶劑中的溶解度,選擇合適的溶劑配制儲(chǔ)備液,并請(qǐng)注意儲(chǔ)備液的保存式和期限。體內(nèi)實(shí)驗(yàn) 請(qǐng)根據(jù)您的實(shí)驗(yàn)動(dòng)物和給藥式選擇適當(dāng)?shù)娜芙獍?,配制前?qǐng)先配制澄清的儲(chǔ)備液,再依次添加助溶劑(為保證實(shí)驗(yàn)結(jié)果的可靠性,體內(nèi)實(shí)驗(yàn)的作液,建

3、議您現(xiàn)現(xiàn)配,當(dāng)天使;澄清的儲(chǔ)備液可以根據(jù)儲(chǔ)存條件,適當(dāng)保存;以下溶劑前的百分 指該溶劑在您配制終溶液中的體積占):1. 請(qǐng)依序添加每種溶劑: 10% DMSO 40% PEG300 5% Tween-80 45% salineSolubility: 2.5 mg/mL (7.76 mM); Clear solution2. 請(qǐng)依序添加每種溶劑: 10% DMSO 90% (20% SBE-CD in saline)Solubility: 2.5 mg/mL (7.76 mM); Clear solution1/3 Master of Small Molecules 您邊的抑制劑師www.Med

4、ChemEBIOLOGICAL ACTIVITY物活性 Dynasore可滲透細(xì)胞的發(fā)動(dòng)蛋抑制劑,IC50為15 M。IC50 & Target IC50: 15 M (GTPase activity of dynamin1 and 2) 1體外研究 Dynasore interferes with the GTPase activity of dynamin1, dynamin2, and Drp1, the mitochondrial dynamin,but not of other small GTPases. Dynasore acts as a potent inhibitor of

5、 endocytic pathways known to dependon dynamin by rapidly blocking coated vesicle formation within seconds of dynasore addition. Two types ofcoated pit intermediates accumulate during dynasore treatment, g-shaped, half formed pits and O-shaped,fully formed pits, captured while pinching off 1. Dynasor

6、e inhibits HSV-1 and HSV-2 infection of humanepithelial and neuronal cells, including primary genital tract cells and human fetal neurons and astrocytes.Dynasore reduces the number of viral capsids reaching the nuclear pore if added at the time of viral entryand that, when added as late as 8 h poste

7、ntry, dynasore blocks the transport of newly synthesized viralproteins from the nucleus to the cytosol 2. Dynasore prevents ischemia/reperfusion induced elevation of leftventricular end diastolic pressure. Dynasore also decreases cardiac troponin I efflux during reperfusion andreduces infarct size.

8、In cultured adult mouse cardiomyocytes subjected to oxidative stress, dynasoreincreases cardiomyocyte survival and viability 3.體內(nèi)研究 Dynasore ameliorates the motor dysfunction greatly at 3, 7, and 10 days after SCI in rats. Dynasoresignificantly enhances motor function which may be by inhibiting the

9、activation of neuronal mitochondrialapoptotic pathway and astrocytic proliferation in rats after SCI 4.PROTOCOLCell Assay 3 Mouse ventricular myocytes are isolated from male adult C6/Black mouse. Cardiomyocytes subjects to 2hours of drug treatment followed by oxidative stress (30 M H2O2 for 35 min).

10、 For ATP supplementexperiments, the cells are treated with 3 mM ATP for 30 min before exposure to H2O2. Cardiomyocytesurvival and viability are analyzed by trypan blue exclusion (TBE) assay 3.MCE has not independently confirmed the accuracy of these methods. They are for reference only.Animal Rats:

11、In the dynasore groups, the rats are given dynasore immediately at a dose of 1, 10, or 30 mg/kgAdministration 4 through intraperitoneal injection after SCI, while the rats in the sham and SCI groups receive DMSO (samevolume as dynasore groups) through intraperitoneal injection 4.MCE has not independ

12、ently confirmed the accuracy of these methods. They are for reference only.戶使本產(chǎn)品發(fā)表的科研獻(xiàn) J Am Chem Soc. 2018 Dec 12;140(49):17234-17240. Oncogene. 2018 Jan 4;37(1):116-127. Drug Deliv. 2018 Nov;25(1):1066-1079. Arab J Chem. 28 June 2018. Eur J Cell Biol. 2019 Jan;98(1):36-50.2/3 Master of Small Molecu

13、les 您邊的抑制劑師www.MedChemESee more customer validations on HYPERLINK / www.MedChemEREFERENCES1. Macia E, et al. Dynasore, a cell-permeable inhibitor of dynamin. Dev Cell. 2006 Jun;10(6):839-50.2. Mues MB, et al. Dynasore disrupts trafficking of herpes simplex virus proteins. J Virol. 2015 Jul;89(13):66

14、73-84.3. Gao D, et al. Dynasore protects mitochondria and improves cardiac lusitropy in Langendorff perfused mouse heart. PLoS One. 2013 Apr15;8(4):e60967.4. Li G, et al. Dynasore Improves Motor Function Recovery via Inhibition of Neuronal Apoptosis and Astrocytic Proliferation after SpinalCord Injury in Rats. Mol Neurobiol. 2

溫馨提示

  • 1. 本站所有資源如無(wú)特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

評(píng)論

0/150

提交評(píng)論